Imexpharm Corporation reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported revenue was VND 256,218.76 million compared to VND 290,018.26 million a year ago. Net income was VND 31,318.99 million compared to VND 50,892.9 million a year ago. Basic earnings per share from continuing operations was VND 413 compared to VND 631 a year ago. For the nine months, revenue was VND 870,079.98 million compared to VND 882,407.02 million a year ago. Net income was VND 122,498.99 million compared to VND 139,318.51 million a year ago. Basic earnings per share from continuing operations was VND 1,679 compared to VND 1,843 a year ago.